On Thursday shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) closed at $63.49. Company’s sales growth for last 5 years was 7.80% and EPS growth for next 5 years is recorded as 0.47%. VIVUS, Inc. (VVUS) has filed a lawsuit in the U.S. District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) in response to an Abbreviated New Drug Application (ANDA) filed by the latter for the generic version of VIVUS’ obesity product Qsymia capsules CIV.
CorMedix, Inc. (NYSEMKT:CRMD) in last trading activity advanced 1.40% to close at $8.67. Company weekly performance is -1.92% while its quarterly performance stands at 280.26%. CorMedix, Inc. (NYSEMKT:CRMD) is -16.63% away from its 52 week high. CorMedix, Inc. (NYSEMKT:CRMD) on April 09, 2015, reported a significant new program aimed at enhancing long term market competitiveness by substantially reducing the cost of goods of Neutrolin® Catheter Lock Solution through a more efficient, custom synthesis of the active ingredient taurolidine.
On Thursday shares of JA Solar Holdings Co., Ltd. (NASDAQ:JASO) closed at $9.97. Company’s sales growth for last 5 years was 5.60% and EPS growth for next 5 years is recorded as 22.00%. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) on April 7th, 2015 announced that the Knesset (Israeli Parliament) has utilized the use of JA PV modules for its rooftop solar project. The Knesset unveiled the 450 kW solar modules installed on its roof at the inauguration of the solar project’s operation on March 29th, 2015.
Royal Caribbean Cruises Ltd. (NYSE:RCL) has 13.50% insider ownership while its institutional ownership stands at 71.60%. In last trading activity company’s stock closed at $80.30. There’s a new tune in the air as global cruise line Royal Caribbean International officially took delivery of its 23rd ship, Anthem of the Seas. Royal Caribbean Cruises Ltd. (NYSE:RCL)’s Chairman and CEO Richard D. Fain officially received the new ship from Meyer Werft Yard’s Managing Partner Bernard Meyer in a signing ceremony held in Bremerhaven, Germany. Anthem of the Seas is the world’s most advanced cruise ship and reflects the best of Royal Caribbean’s history of innovating cruise ship design and cruise vacations.
On last trading day CEL-SCI Corporation (NYSEMKT:CVM) advanced 0.38% to close at $0.95. Its volatility for the week is 3.09% while volatility for the month is 4.89%. CVM’s sales growth for past 5 years was 24.60% and its EPS growth for past 5 years was 31.10%. CEL-SCI Corporation (NYSEMKT:CVM) monthly performance is -12.51%.CEL-SCI Corporation (NYSEMKT:CVM) on 14 April, announced that Aintree University Hospital, in Liverpool, England, has become a clinical site for the Company’s global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). This is the first center to join the Multikine Phase III study in the UK.